Search for: "Upjohn Co., in Re"
Results 21 - 40
of 87
Sort by Relevance
|
Sort by Date
11 Jul 2014, 2:30 pm
” In re Sealed Case, 737 F.2d at 99. [read post]
30 Jun 2014, 4:37 am
Reversing, the appeals court reviewed the history and application of the attorney-client privilege, noting the Supreme Court in Upjohn Co. v. [read post]
19 Jun 2014, 4:00 am
When Willard’s widow sought to reopen his estate in order to exercise her statutory authority to waive the privilege for estate settlement purposes, the North Carolina Supreme Court, in In re Miller, 357 N.C. 316 (2003), found that her true purpose was not to effectuate the goals of the estate but to uncover information relevant to the murder investigation. [read post]
31 Mar 2014, 6:57 pm
They’re available for purchase today. 5. [read post]
26 Dec 2013, 1:27 pm
One of the most contentious and complicated emerging issues of corporate law in the United States is the issue of attorney client privilege when it is asserted by an entity. [read post]
19 Sep 2013, 9:53 am
., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
2 Sep 2013, 5:18 am
’ Upjohn Co. v. [read post]
12 Aug 2013, 7:36 am
The Upjohn Co., 122 F.3d 1476 (Fed. [read post]
5 Jul 2013, 5:00 am
Thus, in In re Zyprexa Products Liability Litigation, 489 F. [read post]
5 Jun 2013, 5:29 am
Searle & Co., 630 F. [read post]
3 Jun 2013, 11:52 am
See Upjohn Co. v. [read post]
28 Feb 2013, 8:10 am
Upjohn Co., 625 P.2d 1192, 1195 (N.M. [read post]
21 Nov 2012, 5:00 am
Merck & Co.,, No. 267003, 2006 WL 1628516, at *3 (Mich. [read post]
9 Aug 2012, 5:00 am
Upjohn (hormone therapy) Trial2008-07-22 Woods v. [read post]
7 May 2012, 5:00 am
Upjohn Co., 835 P.2d 1189, 1195 (Alaska 1992); King v. [read post]
3 Mar 2012, 5:36 pm
Upjohn, 1995 WL 637650, at *4 (D.D.C. 1995) Ambrosini v. [read post]
2 Mar 2012, 6:52 am
Upjohn (hormone therapy) Tria [read post]
1 Feb 2012, 6:00 am
" Upjohn Co. v. [read post]
15 Sep 2011, 4:06 am
Upjohn Co., 813 P.2d 89 (Utah 1991)(“We are persuaded that all prescription drugs should be classified as unavoidably dangerous in design because of th [read post]
27 Aug 2011, 7:55 pm
Upjohn Co., 122 F.3d 1478, 1479 (Fed. [read post]
